High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children
Author(s) -
Minke H. W. Huibers,
Pieter Moons,
Marion Cornelissen,
Fokla Zorgdrager,
Nombulelo Maseko,
Montfort Bernard Gushu,
Oluwadamilola H. Iwajomo,
Michaël Boele van Hensbroek,
Job C. J. Calis
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky348
Subject(s) - medicine , nevirapine , viral load , drug resistance , population , cohort , regimen , prospective cohort study , virology , genotype , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , environmental health , biology , genetics , gene
Drug resistance mutations (DRMs) increasingly jeopardize paediatric HIV programmes in sub-Saharan Africa. As individual monitoring of DRMs and viral loads has limited availability, population data on DRMs are essential to determine first-line susceptibility. Paediatric data from sub-Saharan Africa are scarce and unavailable for Malawi.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom